Dr. Zabransky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Orleans Street
The Johns Hopkins Hospital
Baltimore, MD 21287Phone+1 410-955-7911Fax+1 410-500-4266
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2019 - 2022- Johns Hopkins UniversityResidency, Internal Medicine, 2017 - 2019
- Johns Hopkins University School of MedicineClass of 2017, M.D., Ph.D.
Certifications & Licensure
MD State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1-mutant cholangiocarcinoma.Daniel J Zabransky, Emma Kartalia, Jae W Lee, James M Leatherman, Soren Charmsaz
Hepatology. 2024-12-03 - 1 citationsImmunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma.Daniel H Shu, Won Jin Ho, Luciane T Kagohara, Alexander Girgis, Sarah M Shin
Nature Immunology. 2024-11-01 - Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy.Yash Chhabra, Mitchell E Fane, Sneha Pramod, Laura Hüser, Daniel J Zabransky
Cell. 2024-10-17
Press Mentions
Age-Related Changes in Fibroblast Cells Promote Pancreatic Cancer Growth and SpreadFebruary 21st, 2024- Tip Sheet: Johns Hopkins Kimmel Cancer Center at AACR Annual MeetingApril 9th, 2024
- Tip Sheet: Johns Hopkins Kimmel Cancer Center at AACR Annual MeetingApril 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
